The U.S. Food and Drug Administration has given Ekso Bionics clearance to market its wearable robotic exoskeleton to aid…
Articles by Lindsey Shapiro, PhD
Treatment with Evusheld (tixagevimab co-packaged with cilgavimab) after COVID-19 vaccination significantly boosted the levels of antibodies against the virus…
A protein called nephronectin mediates autoimmunity in a mouse model of multiple sclerosis (MS), and blocking this protein was…
A blood biomarker test developed by Octave can effectively monitor overall disease activity in people with multiple sclerosis…
A single infusion of FibroBiologics‘ investigational cell therapy, CYMS101, was able to inhibit disease activity in a mouse…
The U.S. Department of Defense (DOD) has awarded $3.9 million to fund clinical research to test the impact of a…
Repeated fecal transplants from healthy donors were safe and well-tolerated in a small group of people with relapsing-remitting multiple…
A five-week, high-intensity video game-based exercise program called exergaming outperformed other forms of exercise at easing symptoms and improving life…
Persistent use of a single disease-modifying therapy (DMT) over a three-year period was low among people with relapsing forms…
Genetic variants that contribute to a high body mass index (BMI) during childhood are associated with an increased risk of developing…
Aquatic exercise is used less often by people with multiple sclerosis (MS) than land-based exercise, but it’s generally well…
Gilenya (fingolimod) and Tysabri (natalizumab) were more effective at lowering relapse rates in children with multiple sclerosis…
NervGen Pharma has received approval to enroll a third and final group of healthy volunteers in the multiple ascending…
Disease severity, brain volume loss, and brain lesions are able to predict later cognitive declines in people with relapsing-remitting…
A Phase 3 trial will test the ability of a group resilience training program, called READY, to promote quality of…
Breast cancer is less likely to be detected through a routine cancer screening for women with multiple sclerosis (MS), while…
Rates of multiple sclerosis (MS) were similar among Black and white people, but significantly lower in Hispanics and Asians…
Administering the maresin-1 molecule — a natural anti-inflammatory in the body — in a mouse model of multiple sclerosis…
The portable neuromodulation stimulator (PoNS) device, which improves walking abilities in people with multiple sclerosis (MS), is now…
Quanterix’s ultra-sensitive blood test that measures a biomarker of nerve damage in people with multiple sclerosis (MS) has been…
Kesimpta (ofatumumab) is now accessible to eligible Canadians with relapsing-remitting multiple sclerosis (RRMS) through public drug plans in…
Serum levels of neurofilament light chain (NfL) — proteins found in nerve cell projections — can help in the prediction…
The National Medical Products Administration (NMPA) of China has agreed to approve a Phase 2 trial testing the safety and…
A program aimed at optimizing the use of highly effective therapies successfully lowered treatment costs and relapse rates among people…
Loss of gray matter in the spinal cord clearly associates with greater disability in people with multiple sclerosis (MS),…
Treatment with Gilenya (fingolimod) for up to four years was found safe and lowered relapse rates among people with…
Greater engagement in social activities and positive social support were associated with better physical and psychological health among people with…
About CA$1.35 million ($1.07 million) has been invested in a project that seeks to understand the effects of multiple sclerosis…
Symptoms of Sjögren’s syndrome, including dry eyes and mouth, were observed among 16 people with multiple sclerosis (MS),…
Six weeks of aerobic exercise led to benefits in cognition, fatigue, and depression among people with relapsing-remitting multiple sclerosis…